These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24908234)

  • 1. Fructosamine 3-kinase and glyoxalase I polymorphisms and their association with soluble RAGE and adhesion molecules in diabetes.
    Škrha J; Muravská A; Flekač M; Horová E; Novák J; Novotný A; Prázný M; Škrha J; Kvasnička J; Landová L; Jáchymová M; Zima T; Kalousová M
    Physiol Res; 2014; 63(Suppl 2):S283-91. PubMed ID: 24908234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer.
    Krechler T; Jáchymová M; Mestek O; Zák A; Zima T; Kalousová M
    Clin Biochem; 2010 Jul; 43(10-11):882-6. PubMed ID: 20398646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C332C genotype of glyoxalase 1 and its association with late diabetic complications.
    Groener JB; Reismann P; Fleming T; Kalscheuer H; Lehnhoff D; Hamann A; Roser P; Bierhaus A; Nawroth PP; Rudofsky G
    Exp Clin Endocrinol Diabetes; 2013 Jul; 121(7):436-9. PubMed ID: 23775136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus.
    Skrha J; Kalousová M; Svarcová J; Muravská A; Kvasnička J; Landová L; Zima T; Skrha J
    Exp Clin Endocrinol Diabetes; 2012 May; 120(5):277-81. PubMed ID: 22549347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variability of the fructosamine 3-kinase gene in diabetic patients.
    Mosca L; Penco S; Patrosso MC; Marocchi A; Lapolla A; Sartore G; Chilelli NC; Paleari R; Mosca A
    Clin Chem Lab Med; 2011 May; 49(5):803-8. PubMed ID: 21288167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of the receptor for advanced glycation end-products and glyoxalase I in patients with renal cancer.
    Chocholatý M; Jáchymová M; Schmidt M; Havlová K; Křepelová A; Zima T; Babjuk M; Kalousová M
    Tumour Biol; 2015 Mar; 36(3):2121-6. PubMed ID: 25407489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor for advanced glycation end products (RAGE) and glyoxalase I gene polymorphisms in pathological pregnancy.
    Germanová A; Muravská A; Jáchymová M; Hájek Z; Koucký M; Mestek O; Zima T; Kalousová M
    Clin Biochem; 2012 Nov; 45(16-17):1409-14. PubMed ID: 22771726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the receptor for advanced glycation end products (RAGE) -374 T/A gene polymorphism and circulating soluble RAGE with nephropathy in type 1 diabetic patients.
    Abdel-Azeez HA; El-Okely AM
    Egypt J Immunol; 2009; 16(1):95-106. PubMed ID: 20726326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.
    Gaens KH; Ferreira I; van der Kallen CJ; van Greevenbroek MM; Blaak EE; Feskens EJ; Dekker JM; Nijpels G; Heine RJ; 't Hart LM; de Groot PG; Stehouwer CD; Schalkwijk CG
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5174-80. PubMed ID: 19890027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A polymorphism within the fructosamine-3-kinase gene is associated with HbA1c Levels and the onset of type 2 diabetes mellitus.
    Mohás M; Kisfali P; Baricza E; Mérei A; Maász A; Cseh J; Mikolás E; Szijártó IA; Melegh B; Wittmann I
    Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):209-12. PubMed ID: 19834870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between fructosamine-3 kinase 900C/G polymorphism, transferrin polymorphism and human herpesvirus-8 infection in diabetics living in South Kivu.
    Cikomola JC; Vandepoele K; Katchunga PB; Kishabongo AS; Padalko EY; Speeckaert MM; Delanghe JR
    Acta Trop; 2016 Nov; 163():14-9. PubMed ID: 27461879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetic polymorphisms and activity of glyoxalase 1 as a risk factor for acute coronary syndrome in South Indians with type 2 diabetes mellitus.
    Bora S; Adole PS; Vinod KV; Pillai AA; Ahmed S
    Gene; 2023 Nov; 885():147701. PubMed ID: 37572800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating concentrations of soluble receptor for AGE are associated with age and AGER gene polymorphisms in children with newly diagnosed type 1 diabetes.
    Salonen KM; Ryhänen SJ; Forbes JM; Härkönen T; Ilonen J; Laine AP; Groop PH; Knip M;
    Diabetes Care; 2014 Jul; 37(7):1975-81. PubMed ID: 24742661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of fructosamine-3-kinase in protecting against the onset of microvascular and macrovascular complications in patients with T2DM.
    Sartore G; Ragazzi E; Burlina S; Paleari R; Chilelli NC; Mosca A; Avemaria F; Lapolla A
    BMJ Open Diabetes Res Care; 2020 May; 8(1):. PubMed ID: 32467223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A419C (E111A) polymorphism of the glyoxalase I gene and vascular complications in chronic hemodialysis patients.
    Kalousová M; Germanová A; Jáchymová M; Mestek O; Tesar V; Zima T
    Ann N Y Acad Sci; 2008 Apr; 1126():268-71. PubMed ID: 18079478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the receptor for advanced glycation end products gene polymorphisms and circulating RAGE levels with diabetic retinopathy in the Chinese population.
    Yang L; Wu Q; Li Y; Fan X; Hao Y; Sun H; Cui Y; Han L
    J Diabetes Res; 2013; 2013():264579. PubMed ID: 24303504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of glyoxalase 1 polymorphisms associated with enzyme activity.
    Peculis R; Konrade I; Skapare E; Fridmanis D; Nikitina-Zake L; Lejnieks A; Pirags V; Dambrova M; Klovins J
    Gene; 2013 Feb; 515(1):140-3. PubMed ID: 23201419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glyoxalase I Glu111Ala polymorphism in patients with breast cancer.
    Germanová A; Germanová A; Tesarová P; Jáchymová M; Zvára K; Zima T; Kalousová M
    Cancer Invest; 2009 Jul; 27(6):655-60. PubMed ID: 19452310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites.
    Delpierre G; Veiga-da-Cunha M; Vertommen D; Buysschaert M; Van Schaftingen E
    Diabetes Metab; 2006 Feb; 32(1):31-9. PubMed ID: 16523184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.